| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA676397 | F | Indicates the number of animals that died and survivors lived through 21 days at 25 mg/kg against EMC virus | Encephalomyocarditis virus | 2 | ALA1125167 | organism-based format | Scientific Literature | |
| 2. | ALA673212 | F | Indicates the number of animals that died and survivors lived through 21 days at 50 mg/kg against EMC virus | Encephalomyocarditis virus | 2 | ALA1125167 | organism-based format | Scientific Literature | |
| 3. | ALA673213 | F | In vitro antiviral activity against Encephalomyocarditis virus(EMCV) in mice, at the concentration 1000-1 ug/ml. | Encephalomyocarditis virus | 4 | ALA1151535 | organism-based format | Scientific Literature | |
| 4. | ALA673214 | F | In vitro antiviral activity against Encephalomyocarditis virus(EMCV) in mice, at the concentration 15.6 ug/ml. | Encephalomyocarditis virus | 1 | ALA1151535 | organism-based format | Scientific Literature | |
| 5. | ALA675098 | F | In vitro antiviral activity against Encephalomyocarditis virus(EMCV) in mice, at the concentration 7.8 ug/ml. | Encephalomyocarditis virus | 1 | ALA1151535 | organism-based format | Scientific Literature | |
| 6. | ALA918213 | F | Antiviral activity against encephalomyocarditis virus by CPE assay | Encephalomyocarditis virus | 5 | ALA1144496 | organism-based format | Scientific Literature | |
| 7. | ALA929130 | F | Antiviral activity against encephalomyocarditis virus in wild type mouse fibroblasts assessed as reduction in viral growth | Encephalomyocarditis virus | 2 | ALA1142230 | organism-based format | Scientific Literature | |
| 8. | ALA929131 | F | Antiviral activity against encephalomyocarditis virus in RNaseL deficient mouse fibroblasts assessed as reduction in viral growth | Encephalomyocarditis virus | 2 | ALA1142230 | organism-based format | Scientific Literature | |
| 9. | ALA1004768 | F | Antiviral activity against Encephalomyocarditis virus EMC infected in human HeLa assessed as inhibition of virus-induced cytopathic effect after 2 days by MTT assay | Encephalomyocarditis virus | 10 | ALA1150133 | organism-based format | Scientific Literature | |
| 10. | ALA977501 | F | Antiviral activity against EMC virus infected in human A549 cells assessed as protection against virus-induced cytopathic effect at 100 ug/ml | Encephalomyocarditis virus | 2 | ALA1158698 | organism-based format | Scientific Literature | |
| 11. | ALA1030635 | F | Antiviral activity against EMCV assessed as inhibition of virus-induced cytopathicity | Encephalomyocarditis virus | 4 | ALA1136856 | organism-based format | Scientific Literature | |
| 12. | ALA2044330 | F | Antiviral activity against Encephalomyocarditis virus | Encephalomyocarditis virus | 1 | ALA2040790 | organism-based format | Scientific Literature | |
| 13. | ALA3281972 | F | Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 10 mg/kg, sc administered 28, 22, 2 hrs before and 2 hrs after virus inoculation | Encephalomyocarditis virus | 53 | ALA3272338 | organism-based format | Scientific Literature | |
| 14. | ALA3281973 | F | Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 50 mg/kg, sc administered 28, 22, 2 hrs before and 2 hrs after virus inoculation | Encephalomyocarditis virus | 56 | ALA3272338 | organism-based format | Scientific Literature | |
| 15. | ALA3281974 | F | Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 250 mg/kg, sc administered 28, 22, 2 hrs before and 2 hrs after virus inoculation | Encephalomyocarditis virus | 53 | ALA3272338 | organism-based format | Scientific Literature | |
| 16. | ALA3281975 | F | Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 50 mg/kg, po administered via gavage at 28, 22, 2 hrs before and 2 hrs after virus inoculation | Encephalomyocarditis virus | 43 | ALA3272338 | organism-based format | Scientific Literature | |
| 17. | ALA3281976 | F | Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 250 mg/kg, po administered via gavage as single dose at 22 to 28 hrs before virus inoculation | Encephalomyocarditis virus | 44 | ALA3272338 | organism-based format | Scientific Literature | |
| 18. | ALA3281977 | F | Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 250 mg/kg, sc administered as single dose at 22 hrs before virus inoculation | Encephalomyocarditis virus | 2 | ALA3272338 | organism-based format | Scientific Literature | |
| 19. | ALA3398859 | F | Antiviral activity against Encephalomyocarditis virus infected in HEK293 cells assessed as reduction of viral titer at 25 uM by plaque reduction assay relative to untreated control | Encephalomyocarditis virus | 2 | ALA3396967 | organism-based format | Scientific Literature | |
| 20. | ALA5237214 | F | Antiviral activity against Encephalomyocarditis virus infected in A549 cells assessed as viral growth inhibition incubated for 1 hrs | Encephalomyocarditis virus | 3 | ALA5236550 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!